Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients-Reference-Cited by-同舟云学术

Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients

Author:

Zhang Huiping¹,Wang Jianfeng²,Wang Zhanying³,Ruan Cailian⁴,Wang Lu⁴,Guo Hongtao⁵

Affiliation:

1. Department of Neurology, Baoji Hi-Tech People’s Hospital, Baoji, Shaanxi 721000, China

2. Department of Neurology, Shaanxi Nuclear Industry 215 Hospital, Xianyang, Shaanxi 712000, China

3. Department of Neurology, Xianyang Hospital of Yan’an University, Xianyang, Shaanxi 712000, China

4. Medical College, Yan’an University, Yan’an, Shaanxi 716000, China

5. College of Physical Education, Yan’an University, Yan’an, Shaanxi 716000, China

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference38 articles.

4. Birth of MTH1 as a therapeutic target for glioblastoma: MTH1 is indispensable for gliomatumorigenesis;Tu;Am J Transl Res,2016

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献